Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -55,482 | -35,573 | -19,726 | -27,843 | -19,759 |
| Depreciation Amortization | 1,970 | 911 | 1,602 | 2,253 | 1,889 |
| Accounts payable and accrued liabilities | 1,832 | 1,376 | -1,391 | 640 | 70 |
| Other Working Capital | 8,028 | 937 | -389 | 1,456 | 1,018 |
| Other Operating Activity | -904 | 790 | 1,890 | -464 | 314 |
| Operating Cash Flow | $-44,556 | $-31,559 | $-18,014 | $-23,958 | $-16,468 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,756 | -41,669 | -14,952 | 442 | 26,771 |
| PPE Investments | -6,538 | -2,743 | -307 | -269 | -614 |
| Purchase Sale Intangibles | -675 | -730 | -507 | -1,366 | -1,002 |
| Other Investing Activity | -675 | -730 | -507 | -1,366 | -1,002 |
| Investing Cash Flow | $-5,457 | $-45,142 | $-15,766 | $-1,193 | $25,155 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,000 | 9,500 | -1,375 | 4,590 |
| Debt Repayment | -1,920 | -1,800 | -8,040 | N/A | -1,200 |
| Common Stock Issued | 58,830 | 42,383 | 57,144 | 6,634 | 22,122 |
| Financing Cash Flow | $56,910 | $43,583 | $58,604 | $5,259 | $25,512 |
| Beginning Cash Position | 18,556 | 51,674 | 26,850 | 46,742 | 12,543 |
| End Cash Position | 25,453 | 18,556 | 51,674 | 26,850 | 46,742 |
| Net Cash Flow | $6,897 | $-33,118 | $24,824 | $-19,892 | $34,199 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,556 | -31,559 | -18,014 | -23,958 | -16,468 |
| Capital Expenditure | -6,538 | -2,743 | -307 | -269 | -614 |
| Free Cash Flow | -51,094 | -34,302 | -18,321 | -24,227 | -17,082 |